Global Non opioid Analgesic Patch Market

Global Non-opioid Analgesic Patch Market Research Report 2021

Global Non opioid Analgesic Patch Market

Global Non-opioid Analgesic Patch Market Research Report 2021


The Global Non opioid Analgesic Patch Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like GlaxoSmithKline Plc, Pfizer Inc., Teikoku Seiyaku Co. Ltd., Mylan N.V., Hisamitsu Pharmaceutical Co. Inc, Acorda Therapeutics Inc, Endo International plc, Allergan, Teh Seng Pharmaceutical Mfg, IBSA Institut Biochimque SA

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Research Predicts that Non-opioid Analgesic Patch Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.

Global Non-opioid Analgesic Patch Market Overview:

Global Non-opioid Analgesic Patch Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Non-opioid Analgesic Patch involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

Impact of COVID-19 on Non-opioid Analgesic Patch Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Non-opioid Analgesic Patch market in 2020.

Global Non-opioid Analgesic Patch Market Segmentation

By Type, Non-opioid Analgesic Patch market has been segmented into:

Lidocaine Patches

Diclofenac Patches

Methyl Salicylate Patches

Capsaicin Patches

Ketoprofen Patches

Others

By Application, Non-opioid Analgesic Patch market has been segmented into:

Hospital Pharmacies

Online Pharmacies

Independent Pharmacies & Drug Stores

Regional Analysis:

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

Top Key Players Covered in Non-opioid Analgesic Patch market are:

GlaxoSmithKline Plc

Pfizer Inc.

Teikoku Seiyaku Co. Ltd.

Mylan N.V.

Hisamitsu Pharmaceutical Co. Inc

Acorda Therapeutics Inc

Endo International plc

Allergan

Teh Seng Pharmaceutical Mfg

IBSA Institut Biochimque SA

1. Market Overview of Non-opioid Analgesic Patch

1.1 Non-opioid Analgesic Patch Market Overview

1.1.1 Non-opioid Analgesic Patch Product Scope

1.1.2 Market Status and Outlook

1.2 Non-opioid Analgesic Patch Market Size by Regions: 2015 VS 2021 VS 2026

1.3 Non-opioid Analgesic Patch Historic Market Size by Regions (2015-2020)

1.4 Non-opioid Analgesic Patch Forecasted Market Size by Regions (2021-2026)

1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)

1.5.1 North America

1.5.2 East Asia

1.5.3 Europe

1.5.4 South Asia

1.5.5 Southeast Asia

1.5.6 Middle East

1.5.7 Africa

1.5.8 Oceania

1.5.9 South America

1.5.10 Rest of the World

1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.6.2 Covid-19 Impact: Commodity Prices Indices

1.6.3 Covid-19 Impact: Global Major Government Policy

2. Covid-19 Impact Non-opioid Analgesic Patch Sales Market by Type (2015-2026)

2.1 Global Non-opioid Analgesic Patch Historic Market Size by Type (2015-2020)

2.2 Global Non-opioid Analgesic Patch Forecasted Market Size by Type (2021-2026)

2.3 Lidocaine Patches

2.4 Diclofenac Patches

2.5 Methyl Salicylate Patches

2.6 Capsaicin Patches

2.7 Ketoprofen Patches

2.8 Others

3. Covid-19 Impact Non-opioid Analgesic Patch Sales Market by Application (2015-2026)

3.1 Global Non-opioid Analgesic Patch Historic Market Size by Application (2015-2020)

3.2 Global Non-opioid Analgesic Patch Forecasted Market Size by Application (2021-2026)

3.3 Hospital Pharmacies

3.4 Online Pharmacies

3.5 Independent Pharmacies & Drug Stores

4. Covid-19 Impact Market Competition by Manufacturers

4.1 Global Non-opioid Analgesic Patch Production Capacity Market Share by Manufacturers (2015-2020)

4.2 Global Non-opioid Analgesic Patch Revenue Market Share by Manufacturers (2015-2020)

4.3 Global Non-opioid Analgesic Patch Average Price by Manufacturers (2015-2020)

5. Company Profiles and Key Figures in Non-opioid Analgesic Patch Business

5.1 GlaxoSmithKline Plc

5.1.1 GlaxoSmithKline Plc Company Profile

5.1.2 GlaxoSmithKline Plc Non-opioid Analgesic Patch Product Specification

5.1.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.2 Pfizer Inc.

5.2.1 Pfizer Inc. Company Profile

5.2.2 Pfizer Inc. Non-opioid Analgesic Patch Product Specification

5.2.3 Pfizer Inc. Non-opioid Analgesic Patch Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.3 Teikoku Seiyaku Co. Ltd.

5.3.1 Teikoku Seiyaku Co. Ltd. Company Profile

5.3.2 Teikoku Seiyaku Co. Ltd. Non-opioid Analgesic Patch Product Specification

5.3.3 Teikoku Seiyaku Co. Ltd. Non-opioid Analgesic Patch Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.4 Mylan N.V.

5.4.1 Mylan N.V. Company Profile

5.4.2 Mylan N.V. Non-opioid Analgesic Patch Product Specification

5.4.3 Mylan N.V. Non-opioid Analgesic Patch Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.5 Hisamitsu Pharmaceutical Co. Inc

5.5.1 Hisamitsu Pharmaceutical Co. Inc Company Profile

5.5.2 Hisamitsu Pharmaceutical Co. Inc Non-opioid Analgesic Patch Product Specification

5.5.3 Hisamitsu Pharmaceutical Co. Inc Non-opioid Analgesic Patch Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.6 Acorda Therapeutics Inc

5.6.1 Acorda Therapeutics Inc Company Profile

5.6.2 Acorda Therapeutics Inc Non-opioid Analgesic Patch Product Specification

5.6.3 Acorda Therapeutics Inc Non-opioid Analgesic Patch Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.7 Endo International plc

5.7.1 Endo International plc Company Profile

5.7.2 Endo International plc Non-opioid Analgesic Patch Product Specification

5.7.3 Endo International plc Non-opioid Analgesic Patch Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.8 Allergan

5.8.1 Allergan Company Profile

5.8.2 Allergan Non-opioid Analgesic Patch Product Specification

5.8.3 Allergan Non-opioid Analgesic Patch Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.9 Teh Seng Pharmaceutical Mfg

5.9.1 Teh Seng Pharmaceutical Mfg Company Profile

5.9.2 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Specification

5.9.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Production Capacity, Revenue, Price and Gross Margin (2015-2020)

5.10 IBSA Institut Biochimque SA

5.10.1 IBSA Institut Biochimque SA Company Profile

5.10.2 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product Specification

5.10.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Production Capacity, Revenue, Price and Gross Margin (2015-2020)

6. North America

6.1 North America Non-opioid Analgesic Patch Market Size (2015-2026)

6.2 North America Non-opioid Analgesic Patch Key Players in North America (2015-2020)

6.3 North America Non-opioid Analgesic Patch Market Size by Type (2015-2020)

6.4 North America Non-opioid Analgesic Patch Market Size by Application (2015-2020)

7. East Asia

7.1 East Asia Non-opioid Analgesic Patch Market Size (2015-2026)

7.2 East Asia Non-opioid Analgesic Patch Key Players in North America (2015-2020)

7.3 East Asia Non-opioid Analgesic Patch Market Size by Type (2015-2020)

7.4 East Asia Non-opioid Analgesic Patch Market Size by Application (2015-2020)

8. Europe

8.1 Europe Non-opioid Analgesic Patch Market Size (2015-2026)

8.2 Europe Non-opioid Analgesic Patch Key Players in North America (2015-2020)

8.3 Europe Non-opioid Analgesic Patch Market Size by Type (2015-2020)

8.4 Europe Non-opioid Analgesic Patch Market Size by Application (2015-2020)

9. South Asia

9.1 South Asia Non-opioid Analgesic Patch Market Size (2015-2026)

9.2 South Asia Non-opioid Analgesic Patch Key Players in North America (2015-2020)

9.3 South Asia Non-opioid Analgesic Patch Market Size by Type (2015-2020)

9.4 South Asia Non-opioid Analgesic Patch Market Size by Application (2015-2020)

10. Southeast Asia

10.1 Southeast Asia Non-opioid Analgesic Patch Market Size (2015-2026)

10.2 Southeast Asia Non-opioid Analgesic Patch Key Players in North America (2015-2020)

10.3 Southeast Asia Non-opioid Analgesic Patch Market Size by Type (2015-2020)

10.4 Southeast Asia Non-opioid Analgesic Patch Market Size by Application (2015-2020)

11. Middle East

11.1 Middle East Non-opioid Analgesic Patch Market Size (2015-2026)

11.2 Middle East Non-opioid Analgesic Patch Key Players in North America (2015-2020)

11.3 Middle East Non-opioid Analgesic Patch Market Size by Type (2015-2020)

11.4 Middle East Non-opioid Analgesic Patch Market Size by Application (2015-2020)

12. Africa

12.1 Africa Non-opioid Analgesic Patch Market Size (2015-2026)

12.2 Africa Non-opioid Analgesic Patch Key Players in North America (2015-2020)

12.3 Africa Non-opioid Analgesic Patch Market Size by Type (2015-2020)

12.4 Africa Non-opioid Analgesic Patch Market Size by Application (2015-2020)

13. Oceania

13.1 Oceania Non-opioid Analgesic Patch Market Size (2015-2026)

13.2 Oceania Non-opioid Analgesic Patch Key Players in North America (2015-2020)

13.3 Oceania Non-opioid Analgesic Patch Market Size by Type (2015-2020)

13.4 Oceania Non-opioid Analgesic Patch Market Size by Application (2015-2020)

14. South America

14.1 South America Non-opioid Analgesic Patch Market Size (2015-2026)

14.2 South America Non-opioid Analgesic Patch Key Players in North America (2015-2020)

14.3 South America Non-opioid Analgesic Patch Market Size by Type (2015-2020)

14.4 South America Non-opioid Analgesic Patch Market Size by Application (2015-2020)

15. Rest of the World

15.1 Rest of the World Non-opioid Analgesic Patch Market Size (2015-2026)

15.2 Rest of the World Non-opioid Analgesic Patch Key Players in North America (2015-2020)

15.3 Rest of the World Non-opioid Analgesic Patch Market Size by Type (2015-2020)

15.4 Rest of the World Non-opioid Analgesic Patch Market Size by Application (2015-2020)

16 Non-opioid Analgesic Patch Market Dynamics

16.1 Covid-19 Impact Market Top Trends

16.2 Covid-19 Impact Market Drivers

16.3 Covid-19 Impact Market Challenges

16.4 Porter’s Five Forces Analysis

18 Regulatory Information

17 Analyst's Viewpoints/Conclusions

18 Appendix

18.1 Research Methodology

18.1.1 Methodology/Research Approach

18.1.2 Data Source

18.2 Disclaimer

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Non opioid Analgesic Patch Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Who are the dominant players having a strong presence in the Non opioid Analgesic Patch Market?
Some of the finest and top-notch companies pioneering the Non opioid Analgesic Patch Market are GlaxoSmithKline Plc, Pfizer Inc., Teikoku Seiyaku Co. Ltd., Mylan N.V., Hisamitsu Pharmaceutical Co. Inc, Acorda Therapeutics Inc, Endo International plc, Allergan, Teh Seng Pharmaceutical Mfg, IBSA Institut Biochimque SA.
What is the major concern of the players in the Non opioid Analgesic Patch Market?
As manufacturers prepare to scale up, Non opioid Analgesic Patch companies must be clear and transparent about the impact of such volatility on the balance sheet.
What are the major applications for Non opioid Analgesic Patch?
Non opioid Analgesic Patch has a wide range of applications, including and others.
What is the expected rate of growth in the Non opioid Analgesic Patch Market?
From 2025 to 2030, the Non opioid Analgesic Patch Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
What does the future hold for the Non opioid Analgesic Patch Market?
As the shift to value addition continues, companies in the Non opioid Analgesic Patch Market face the dual challenge of improving interoperability to optimize performance and experience.
How is the Non opioid Analgesic Patch Market's changing dynamics captured?
The Non opioid Analgesic Patch analysis provides high-level qualitative commentary on market dynamics, including information on growth drivers, influential trends, challenges, and opportunities.